Global Markets Rally on Trade Optimism, Alzheimer’s Breakthrough, and China’s Industrial Surge
Key Takeaways Health Canada has granted conditional authorization for Eisai's (ESALY) LEQEMBI® (lecanemab), marking it as the first treatment in […]
Breaking News
Global Markets React to Brazil’s Economic Shifts, Japan’s U.S. Investment Pledge, and Soaring Precious Metals Forecasts
Key Takeaways Brazil's economic outlook shows slight downward revisions for 2025 and 2026 GDP growth and inflation, while the Brazilian
Global Markets React to Key Developments in Tech, Geopolitics, and Fast Food
Key Takeaways Amazon (AMZN) has pledged over €1.4 billion (approximately $1.63 billion) for its AWS and retail operations in the
Global Markets React to Trade Truce, Geopolitical Tensions, and Key Earnings
Key Takeaways A tentative US-China trade framework has averted a 100% tariff increase on Chinese imports and will see China
Global Tensions Escalate as Trade Wars Brew and Nuclear Tests Loom
Key Takeaways Canadian Prime Minister Mark Carney is navigating escalating trade tensions with the United States, as President Trump has
Global Markets React to PBoC Policy Shift, German Optimism, and Nikkei Rebalancing
Key Takeaways China's central bank (PBoC) is set to resume government bond trading in the open market and will implement
RBA Signals Higher-for-Longer Rates Amid Inflation Concerns; UK Eyes Public Finance Overhaul
Key Takeaways RBA Governor Michele Bullock indicated that Australian interest rates might not decline as significantly as those of other
Global Markets React to Trade Hopes, Central Bank Commentary, and Geopolitical Shifts
Key Takeaways Reserve Bank of Australia (RBA) Governor Michele Bullock highlighted Australia's strong employment market outcomes compared to other nations,
Global Diplomacy, Energy Shifts, and Corporate Moves Shape Monday’s Market Outlook
Key Takeaways Canadian Prime Minister Mark Carney met with Malaysian Prime Minister Anwar Ibrahim, signaling strengthened diplomatic ties, while South
Global Markets Navigate Diplomatic Tensions, Pharma Innovation, and Mixed Economic Signals
Key Takeaways GSK (GSK) has secured exclusive worldwide rights for a preclinical antibody drug conjugate (ADC) from Syndivia to target